Daniele Cusi Selected Research

Hydrochlorothiazide (Esidrix)

6/2015	TET2 and CSMD1 genes affect SBP response to hydrochlorothiazide in never-treated essential hypertensives.
3/2003	ACE and alpha-adducin polymorphism as markers of individual response to diuretic therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniele Cusi Research Topics

Disease

22	Hypertension (High Blood Pressure) 01/2022 - 02/2002
9	Essential Hypertension 01/2021 - 03/2003
8	Vascular Calcification 11/2012 - 01/2010
7	Nephrolithiasis 01/2018 - 03/2011
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 01/2011
5	Chronic Renal Insufficiency 04/2014 - 01/2011
4	Renal Insufficiency (Renal Failure) 01/2022 - 05/2006
4	Kidney Calculi (Kidney Stone) 10/2018 - 11/2011
4	Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets) 01/2013 - 01/2011
3	Atherosclerosis 01/2016 - 01/2010
3	Chronic Kidney Failure (Chronic Renal Failure) 11/2012 - 09/2009
3	Hyperphosphatemia 03/2012 - 01/2011
3	Proteinuria 02/2010 - 01/2007
2	Disease Susceptibility (Diathesis) 05/2022 - 01/2022
2	Brugada Syndrome 05/2022 - 01/2022
2	Multiple Sclerosis 10/2015 - 01/2013
2	Bone Diseases (Bone Disease) 01/2013 - 03/2012
2	Secondary Hyperparathyroidism 01/2013 - 01/2011
2	Fibrosis (Cirrhosis) 01/2007 - 01/2004
2	Hypercalciuria 12/2003 - 10/2002
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Gout 10/2019
1	Glaucoma 01/2017
1	Exfoliation Syndrome 01/2017
1	Diabetes Mellitus 01/2017
1	Frontotemporal Dementia (Semantic Dementia) 01/2017
1	Autism Spectrum Disorder 10/2016
1	Hypersensitivity (Allergy) 01/2016
1	Myofibrillar Myopathy 01/2016
1	Liver Diseases (Liver Disease) 09/2015
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 09/2015
1	Moyamoya Disease (Moya-Moya Disease) 09/2015
1	Thoracic Aortic Aneurysm 09/2015
1	Edema (Dropsy) 05/2015
1	Systemic Scleroderma (Systemic Sclerosis) 03/2015
1	Obesity 02/2015
1	Vitamin K Deficiency 02/2015
1	Primary Hyperparathyroidism 02/2015

Drug/Important Bio-Agent (IBA)

10	CalciumIBA 10/2018 - 12/2003
10	adducinIBA 11/2010 - 02/2002
7	SaltsIBA 01/2020 - 07/2003
6	Calcium-Sensing ReceptorsIBA 02/2015 - 10/2002
5	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 01/2013
5	Proteins (Proteins, Gene)FDA Link 01/2016 - 10/2002
5	Vitamin D FDA LinkGeneric 01/2013 - 11/2010
4	Pharmaceutical PreparationsIBA 01/2022 - 11/2010
4	SodiumIBA 01/2020 - 03/2003
4	AldosteroneIBA 06/2015 - 01/2004
4	MineralsIBA 01/2013 - 11/2010
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 05/2006
3	Biological ProductsIBA 01/2022 - 11/2010
3	LipidsIBA 01/2016 - 05/2006
3	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2013 - 01/2011
3	Parathyroid Hormone (Parathormone)IBA 03/2012 - 01/2011
2	Sodium Channels (Sodium Channel)IBA 05/2022 - 01/2022
2	HDL CholesterolIBA 01/2022 - 01/2017
2	rostafuroxinIBA 01/2021 - 11/2010
2	Uric Acid (Urate)IBA 10/2019 - 11/2016
2	Matrix Gla ProteinIBA 01/2018 - 02/2015
2	DiureticsIBA 01/2017 - 03/2003
2	Transcription Factors (Transcription Factor)IBA 01/2017 - 11/2013
2	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 06/2015 - 03/2003
2	Hormones (Hormone)IBA 01/2013 - 01/2012
2	Phosphates (Orthophosphate)IBA 11/2012 - 03/2012
2	Phosphorus (Red Phosphorus)IBA 01/2012 - 01/2011
2	paricalcitol (Zemplar)FDA Link 01/2011 - 01/2011
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2007 - 01/2007
1	Inositol PhosphatesIBA 01/2022
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2022
1	CreatinineIBA 01/2022
1	Losartan (Cozaar)FDA LinkGeneric 01/2021
1	Saline SolutionIBA 01/2020
1	Sodium Chloride FDA LinkGeneric 10/2018
1	claudin 14IBA 10/2018
1	Vitamin K FDA Link 01/2018
1	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Xanthine OxidaseIBA 11/2016
1	NeuroliginsIBA 10/2016
1	Deoxyribonuclease I (Nickase)IBA 01/2016
1	ChromatinIBA 01/2016
1	PolyphenolsIBA 01/2016
1	Aryldialkylphosphatase (Paraoxonase)IBA 01/2016
1	HLA Antigens (Human Leukocyte Antigens)IBA 10/2015
1	Cytoplasmic DyneinsIBA 09/2015
1	Myosin-Light-Chain KinaseIBA 09/2015
1	Diltiazem (Cardizem)FDA LinkGeneric 06/2015
1	Gentamicins (Gentamicin)FDA LinkGeneric 05/2015
1	MorpholinosIBA 05/2015
1	InterferonsIBA 03/2015
1	Glutamic Acid (Glutamate)FDA Link 02/2015
1	IsotopesIBA 04/2014
1	AcidsIBA 04/2014

Therapy/Procedure

5	Therapeutics 03/2016 - 03/2003
3	Renal Dialysis (Hemodialysis) 01/2010 - 09/2009
2	Transplantation 01/2022 - 08/2007
1	Precision Medicine 03/2016
1	Immunomodulation 09/2015
1	Mediterranean Diet 02/2014